Notice of Annual General Meeting 2023
Copenhagen, Denmark, 15 March 2023 – Notice is hereby given of the annual general meeting of Curasight A/S ("Curasight" or the "Company" – TICKER: CURAS).
The Board of Directors is pleased to invite shareholders to the Annual General Meeting of Curasight A/S, to be held on
Thursday 30 March 2023 at 10:00 AM (CEST) at COBIS, Ole Maaløes Vej 3, DK-2200 Copenhagen
Agenda
- The Board of Directors’ report on the Company’s activities in the preceding financial year
- Presentation and approval of the annual report
- Appropriation of profit or covering of loss as recorded in the adopted annual report
- Election of members to the Board of Directors
- Election of auditor
Complete proposals
- The Board of Directors’ report on the Company’s activities in the past financial year
- Presentation and adoption of the annual report
The Board of Directors proposes that the annual report for the financial year 2022 is adopted.
- Appropriation of loss as recorded in the adopted annual report
The Board of Directors proposes that the result for 2022 is carried forward to next year in accordance with the annual report for 2022.
- Election of members to the Board of Directors
The Board of Directors proposes re-election of:
- Per Falholt
- Lars Trolle
- Kirsten Aarup Drejer
- Charlotte Vedel
- Andreas Kjær
- Ulrich Krasilnikoff
- Election of auditor
The Board of Directors proposes re-election of PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab, CVR no. 33 77 12 31, as auditor of the Company.
*****
Majority requirements
Adoption of the proposals set out in items 2–5 of the agenda are subject to a simple majority of votes, cf. section 105 of the Danish Companies Act.
Share capital and voting rights
On the date of this notice, the nominal share capital of Curasight is DKK 994,694.55 divided into shares of a nominal value of DKK 0.05 each. Each share of nominally DKK 0.05 carries one vote (19,893,891 votes in total).
Participation and voting rights
All shareholders holding shares in the Company on the date of registration have a right to attend and vote at the Annual General Meeting. The date of registration is Thursday 23 March 2023.
The number of shares held by each shareholder at the date of registration is based on information recorded in the Company’s shareholders’ register at the expiry of the registration date as well as any notification received by the Company for registration but not yet entered in the shareholders’ register at the expiry of the registration date.
Registration and notice of attendance
A shareholder wishing to attend the Annual General Meeting is requested to notify the Company of the shareholder’s attendance no later than on Friday 24 March 2023 at 23.59 (CET). Attendance can be notified by completing, signing, and returning a dated registration form (notification of attendance) by email to uk@curasight.com. Registration forms can be found at www.curasight.com/investor/general-meetings/.
A shareholder or its proxy holder wishing to register an advisor for attending the Annual General Meeting must state the name and email address of the advisor, when submitting the notification of attendance.
Proxy
Shareholders may attend the Annual General Meeting by proxy to the Board of Directors or a third party. Proxies can be granted by completing, signing, and returning a dated proxy form. Proxy forms can be found at www.curasight.com/investor/general-meetings/.
Proxies must be received by the Company no later than Friday 24 March 2023 at 23.59 (CET) as a scanned copy by email to uk@curasight.com.
Proxies can be revoked by the shareholder at any time. Revocation must be in writing by e-mail to uk@curasight.com and include proper identification of the shareholder revoking the proxy.
Postal vote
Shareholders may vote by post with respect to the agenda items of the Annual General Meeting. Postal votes can be submitted by completing, signing, and returning a dated postal vote form. Postal vote forms can be found at www.curasight.com/investor/general-meetings/.
Postal votes must be received by the Company no later than Wednesday 29 March 2023 at 9.00 AM (CEST) as scanned copy by email to uk@curasight.com.
Postal votes cannot be revoked.
Information at the Company’s website
Further information on the Annual General Meeting and the following information and documents will be available at the Company's website www.curasight.com/investor/general-meetings/ until and including the date of the Annual General Meeting:
- The notice convening the Annual General Meeting, including the agenda and complete proposals
- The total number of shares and voting rights as of the date of this notice
- The annual report for 2022
- The documents to be submitted to the Annual General Meeting
- Proxy/postal voting forms applicable to the Annual General Meeting
Questions from shareholders
Any shareholder can ask questions to the Board of Directors and the Executive Management about the annual report for 2022, the Company in general or the agenda items prior to the Annual General Meeting. Such questions can be submitted by email to uk@curasight.com.
Questions from shareholders submitted prior to the Annual General Meeting will, as far as possible, be answered in writing prior to the Annual General Meeting or presented by the chairman of the Annual General Meeting and answered at the Annual General Meeting, provided that the shareholder concerned attend the Annual General Meeting.
Moreover, shareholders can ask questions at the Annual General Meeting. If a question cannot be answered at the Annual General Meeting, the answer will be published on the Company’s website, www.curasight.com, no later than two weeks after the Annual General Meeting.
Personal data
Prompted by requirements set out in the Danish Companies Act, the Company processes personal information about its shareholders as part of the administration of the company's register of shareholders and other communications. The following information is processed: Name, address, contact information, VP account number, shareholding and participation in events.
Language
The Annual General Meeting will be conducted in Danish and all representatives of the Company and the chairman of the Annual General Meeting will make their presentations and answer questions in Danish.
*****
The Board of Directors
15 March 2023
For more information regarding Curasight, please contact:
Ulrich Krasilnikoff, CEO
Phone: +45 22 83 01 60
E-mail: uk@curasight.com
Curasight is a clinical development company based in Copenhagen, Denmark. The Company is a pioneer in the field of exploiting a novel Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (“uPAR”). The technology provides improved diagnosis and risk stratification in multiple cancer types.